A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01629407
Recruitment Status : Completed
First Posted : June 27, 2012
Last Update Posted : June 20, 2013
Information provided by (Responsible Party):

Brief Summary:
This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Condition or disease Intervention/treatment
Glaucoma, Open-Angle Other: Standard of Care

Study Type : Observational
Actual Enrollment : 315 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : June 2009
Primary Completion Date : May 2013
Study Completion Date : May 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Group/Cohort Intervention/treatment
Patients with glaucoma
Other: Standard of Care
Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.

Primary Outcome Measures :
  1. Change from Baseline in Visual Field [ Time Frame: Baseline, 24 Months ]

Secondary Outcome Measures :
  1. Change from Baseline in Intraocular Pressure (IOP) [ Time Frame: Baseline, 24 Months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with primary open angle glaucoma in one or both eyes

Inclusion Criteria:

  • Glaucoma in one or both eyes

Exclusion Criteria:

  • Participation in a glaucoma therapeutic clinical trial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01629407

Barcelona, Spain
Sponsors and Collaborators
Study Director: Medical Director Allergan

Responsible Party: Allergan Identifier: NCT01629407     History of Changes
Other Study ID Numbers: MAF/AGN/OPH/GLA/015
First Posted: June 27, 2012    Key Record Dates
Last Update Posted: June 20, 2013
Last Verified: June 2013

Additional relevant MeSH terms:
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases